Generation Net Income From Continuing Ops from 2010 to 2026
| GBIO Stock | USD 5.62 0.08 1.40% |
Net Loss | First Reported 2019-03-31 | Previous Quarter -20.9 M | Current Value -5.5 M | Quarterly Volatility 12.8 M |
Check Generation Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Generation Bio's main balance sheet or income statement drivers, such as Net Interest Income of 12.9 M, Interest Income of 6.5 M or Depreciation And Amortization of 4 M, as well as many indicators such as Price To Sales Ratio of 3.88, Dividend Yield of 0.0 or PTB Ratio of 0.77. Generation financial statements analysis is a perfect complement when working with Generation Bio Valuation or Volatility modules.
Generation | Net Income From Continuing Ops | Build AI portfolio with Generation Stock |
Evaluating Generation Bio's Net Income From Continuing Ops across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Generation Bio Co's fundamental strength.
Latest Generation Bio's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Generation Bio Co over the last few years. It is Generation Bio's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Generation Bio's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Generation Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (71,827,321) | |
| Coefficient Of Variation | (60.12) | |
| Mean Deviation | 39,379,907 | |
| Median | (35,803,000) | |
| Standard Deviation | 43,180,796 | |
| Sample Variance | 1864.6T | |
| Range | 100.8M | |
| R-Value | (0.88) | |
| Mean Square Error | 433.3T | |
| R-Squared | 0.78 | |
| Slope | (7,562,379) | |
| Total Sum of Squares | 29833.3T |
Generation Net Income From Continuing Ops History
About Generation Bio Financial Statements
Generation Bio investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Generation Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -118.5 M | -124.4 M |
Pair Trading with Generation Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Generation Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Generation Stock
Moving against Generation Stock
| 0.71 | ABP | Abpro Holdings | PairCorr |
| 0.66 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.6 | KURA | Kura Oncology | PairCorr |
| 0.58 | IMRN | Immuron Ltd ADR | PairCorr |
| 0.5 | LYRA | Lyra Therapeutics | PairCorr |
The ability to find closely correlated positions to Generation Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Generation Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Generation Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Generation Bio Co to buy it.
The correlation of Generation Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Generation Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Generation Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Generation Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Generation Bio Correlation against competitors. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Will Biotechnology sector continue expanding? Could Generation diversify its offerings? Factors like these will boost the valuation of Generation Bio. Market participants price Generation higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Generation Bio data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (9.47) | Revenue Per Share | Quarterly Revenue Growth (0.79) | Return On Assets | Return On Equity |
Generation Bio's market price often diverges from its book value, the accounting figure shown on Generation's balance sheet. Smart investors calculate Generation Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Generation Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.